We recognise there is more to do to meet the needs of patients with CKD-related anaemia, and that challenges remain. However, we are confident that by following the science these challenges can be overcome.
 National Institute of Diabetes and Digestive and Kidney Diseases. Anaemia in Chronic Kidney Disease. Available at: https://www.niddk.nih.gov/health-information/kidney-disease/anemia Last accessed June 2020
 Hill, N.R et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS One. 2016 Jul 6;11(7):e0158765.
 GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systemic analysis for the Global Burden of Disease Study 2017. The Lancet. Volume 395, Issue 10225, p709-733; February 29, 2020.
 Babitt, J.L and Lin, H.Y. Mechanisms of Anemia in CKD. J Am Soc Nephrol. 2012 Sep 28; 23;(10):1631-1634.
 The Guardian. Nobel prize in medicine awarded to hypoxia researchers. Available at: https://www.theguardian.com/science/2019/oct/07/nobel-prize-in-medicine-awarded-to-hypoxia-researchers Last accessed June 2020.
 Schodel, J and Ratcliffe, P.J. Mechanisms of hypoxia signalling: new implications for nephrology. Nat Rev Nephrol. 2019 Oct;15(10):641-659.
 Gupta N, Wish JB. Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD. Am J Kidney Dis. 2017.1;69(6):815-26.